The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| MED | -29.01% | -90.53% | -37.57% | +204% |
| S&P | +16.23% | +94.45% | +14.22% | +1,338% |
Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm’s product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.
The average analyst 12-month price target of the nutrition and weight loss stock works out to a mind-boggling 171% upside.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $105.56M | -37.4% |
| Gross Profit | $76.64M | -37.9% |
| Gross Margin | 72.61% | -0.6% |
| Market Cap | $154.42M | -35.3% |
| Market Cap / Employee | $0.31M | 0.0% |
| Employees | 504 | -20.5% |
| Net Income | $2.48M | 130.4% |
| EBITDA | $2.98M | 161.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $101.69M | -5.9% |
| Inventory | 30.2 | -23.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $7.14M | -45.3% |
| Short Term Debt | $5.92M | -1.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 1.29% | -8.3% |
| Return On Invested Capital | 52.55% | -13.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$4.76M | -142.7% |
| Operating Free Cash Flow | -$3.38M | -125.8% |
| Metric | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 8.14 | 28.64 | 93.13 | 42.63 | 589.73% |
| Price to Book | 1.02 | 0.93 | 0.70 | 0.73 | -35.29% |
| Price to Sales | 0.31 | 0.32 | 0.27 | 0.32 | 4.38% |
| Price to Tangible Book Value | 1.02 | 0.93 | 0.70 | 0.73 | -35.29% |
| Price to Free Cash Flow TTM | 13.51 | 13.87 | 11.87 | 11.12 | -20.24% |
| Enterprise Value to EBITDA | 10.88 | 5.51 | -1.19 | 1.94 | -109.91% |
| Free Cash Flow Yield | 7.4% | 7.2% | 8.4% | 9.0% | 25.37% |
| Return on Equity | 3.7% | 1.0% | -3.3% | 1.7% | -88.49% |
| Total Debt | $17.63M | $16.13M | $14.61M | $13.07M | -31.58% |
MED earnings call for the period ending September 30, 2021.
MED earnings call for the period ending June 30, 2021.
MED earnings call for the period ending March 31, 2021.
MED earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
